Pharmacologic stress myocardial perfusion imaging

Southern Medical Journal

Volumn 100, Issue 10, 2007, Pages 1006-1014

  Patel, Rakesh N ^b   Arteaga, Roque B ^b   Mandawat, Mahendra K ^b   Thornton, John W ^b   Robinson, Vincent J B ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NONE

Author keywords

Choice of stress tests; Coronary heart disease; Vasodilator stress testing

Indexed keywords

ADENOSINE; AMINOPHYLLINE; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPYRIDAMOLE; DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE; THALLIUM 201;

BLOOD PRESSURE; BLURRED VISION; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC PROCEDURE; DRUG MEGADOSE; DYSPNEA; EXERCISE; EXERCISE ELECTROCARDIOGRAPHY; HEART ATRIUM ARRHYTHMIA; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PACING; HEART PERFUSION; HEART RATE; HEART VENTRICLE; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMAGE QUALITY; INCIDENCE; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MYOCARDIAL PERFUSION IMAGING; PHARMACOLOGIC STRESS TESTING; PREOPERATIVE EVALUATION; REVASCULARIZATION; REVIEW; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASODILATATION;

CORONARY CIRCULATION; DIABETES COMPLICATIONS; DIAGNOSTIC IMAGING; EXERCISE TEST; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; VASODILATOR AGENTS;

EID: 35148866179     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318153f9c6     Document Type: Review

References (55)

1. Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med 1999; 130:719-728.
2. Mark DB, Hlatky MA, Harrell FE Jr, et al. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 1987; 106:793-800.
3. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina. Circulation 2003;107:158.
4. Kim C, Kwok YS, Heagerty P, et al. Pharmacologic stress testing for coronary disease diagnosis: a meta-analysis. Am Heart J 2001;142:934-944.
5. Lee TH, Boucher CA. Noninvasive tests in patients with stable coronary artery disease. N Engl J Med 2001;344:1840-1850.
6. Chan SY, Brunken RC, Czernin J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 1992;20:979-985.
7. Uren NG, Melin JA, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994;330:1782-1788.
8. Akinboboye OO, Idris O, Chou RL, et al. Absolute quantitation of coronary steal induced by intravenous dipyridamole. J Am Coll Cardiol 2001;37:109-116.
9. Hays JT, Mahmarian JJ, Cochran AJ, et al. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993;21:1583-1590.
10. Meyer R, Frishman WH. Cholinergic and Anticholinergic Drugs. Cardiovascular Pharmacotherapeutics Manual. Frishman WH, Sonnenblick EH, Sica DA (eds). New York, McGraw-Hill Medical Publishing Division, 2nd Ed, 2004, pp 58-64.
11. Heller GV, Dweik RB, Barbour MM, et al. Pretreatment with theophylline does not affect adenosine-induced thallium-201 myocardial imaging. Am Heart J 1993;126:1077-1083.
12. Bottcher M, Czernin J, Sun KT, et al. Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J Nucl Med 1995;36:2016-2021.
13. Smits P, Corstens FH, Aengevaeren WR, et al. False-negative dipyridamole-thallium-201 myocardial imaging after caffeine infusion. J Nucl Med 1991;32:1538-1541.
14. Zoghbi GJ, Htay T, Aqel R, et al. Effect of Caffeine on Ischemia Detection by Adenosine Single-Photon Emission Computed Tomography Perfusion Imaging. J Am Coll Cardiol 2006;47:2296-2302.
15. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging- executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318-1333.
16. Taillefer R, Ahlberg AW, Maood Y, et al. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol 2003;42: 1475-1483.
17. Bottcher M, Refsgaard J, Madsen MM, et al. Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia. J Nucl Cardiol 2003;10:345-352.
18. Shehata AR, Gillam LD, Mascitelli VA, et al. Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography. Am J Cardiol 1997;80:268-272.
19. Mahmarian JJ, Shaw LJ, Filipchuk NG, et al. A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low risk group for early hospital discharge after acute myocardial infarction. J Am Coll Cardiol 2006;48:2448-2457.
20. Thurnheer R, Laube I, Kaufmann PA, et al. Practicability and safety of dipyridamole cardiac imaging in patients with severe chronic obstructive pulmonary disease. Eur J Nucl Med 1999;26:812-817.
21. Pennell DJ, Underwood SR, Ell PJ. Safety of dobutamine stress for thallium-201 myocardial perfusion tomography in patients with asthma. Am J Cardiol 1993;71:1346-1350.
22. Mertes H, Sawada SG, Ryan T, et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography: exerience in 1118 patients. Circulation 1993;88:15-19.
23. Iskandrian AS, Verani MS. Exercise Perfusion Imaging in Coronary Artery Disease: Physiology and Diagnosis. In: Nuclear Cardiac Imaging: Principles and Applications, Philadelphia, FA Davis, 1996, pp 73-143.
24. Geleijnse ML, Elhendy A, Fioretti PM, et al. Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol 2000;36:2017-2027.
25. Robinson VJB, Pasi M, Reece S, et al. Choosing a stress test. Urban Cardiology 2002; January/February; 15.
26. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA Guidelines for Exercise Testing: a report of the American College of Cardiology/American Heart Association Task Force on practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997;30:260-311.
27. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002;106:1883-1892.
28. Pennell DJ, Mavrogeni SI, Forbat SM, et al. Adenosine combined with dynamic exercise for myocardial perfusion imaging. J Am Coll Cardiol 1995;25:1300-1309.
29. Thomas GS, Prill NV, Majmudar H, et al. Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality. J Nucl Cardiol 2000;7:439-446.
30. Stein L, Burt R, Oppenheim B, et al. Symptom-limited arm exercise increases detection of ischemia during dipyridamole tomographic thallium stress testing in patients with coronary artery disease. Am J Cardiol 1995;75:568-572.
31. Holly TA, Satran A, Bromet DS, et al. The impact of adjunctive adenosine infusion during exercise myocardial perfusion imaging: Results of the Both Exercise and Adenosine Stress Test (BEAST) trial. J Nucl Cardiol 2003;10:291-296.
32. Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003;41:1125-1133.
33. Kang X, Berman DS, Lewin HC, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999;138:1025-1032.
34. Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40.
35. De Lorenzo A, Lima RS, Siqueira-Filho AG, et al. Prevalence and prognostic value of perfusion defects detected by stress technetium- 99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 2002;90:827-832.
36. Wackers FTJ, Young LH, Chyun DA, et al. Predictors of silent myocardial ischemia in patients with type 2 diabetes mellitus: results from the DIAD study. Detection of Ischemia in Asymptomatic Diabetics. Diabetologia 2003;46(Suppl 2):A23-A24.
37. Wackers FJ, Young LH, Inzucchi SE, et al, for the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators.Detection of silent myocardial ischemia in asymptomatic diabetic subjects. Diabetes Care 2004;27:1954-1961.
38. Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95:2037-2043.
39. Zellweger MJ, Hachamovitch R, Kang X, et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J 2004;25:543-550.
40. Rees G, Bristow JD, Kremkau EL, et al. Influence of aortocoronary bypass surgery on left ventricular performance. N Engl J Med 1971;284: 1116-1120.
41. Chatterjee K, Swan HJ, Parmley WW, et al. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease: with and without previous myocardial infarction. Circulation 1973;47:276-286.
42. Brundage BH, Massie BM, Botvinick EH. Improved regional ventricular function after successful surgical revascularization. J Am Coll Cardiol 1984;3:902-908.
43. Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-1158.
44. Vaduganathan P, He ZX, Raghavan C, et al. Detection of left anterior descending coronary artery stenosis in patients with left bundle branch block: exercise, adenosine or dobutamine imaging? J Am Coll Cardiol 1996;28:543-550.
45. Caner B, Rezaghi C, Uysal U, et al. Dobutamine Thallium-201 Myocardial SPECT in Patients with Left Bundle Branch Block and Normal Coronary Arteries. J Nucl Med 1997;38:424-427.
46. Lakkis NM, He ZX, Verani MS. Diagnosis of coronary artery disease by exercise thallium-201 tomography in patients with a right ventricular pacemaker. J Am Coll Cardiol 1997;29:1221-1225.
47. Tse HF, Lau CP. Long-term effect of right ventricular pacing on myocardial perfusion and function. J Am Coll Cardiol 1997;29:744-749.
48. Ciaroni S, Bloch A, Albrecht L, et al. Diagnosis of coronary artery disease in patients with permanent cardiac pacemaker by dobutamine stress echocardiography or exercise thallium-201 myocardial tomography. Echocardiography 2000;17:675-679.
49. Etchells E, Meade M, Tomlinson G, et al. Semiquantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: a meta-analysis. J Vasc Surg 2002;36: 534-540.
50. Lette J, Waters D, Cerino M, et al. Preoperative coronary artery disease risk stratification based on dipyridamole imaging and a simple, three-step, three-segment model for patients undergoing noncardiac vascular surgery or major general surgery. Am J Cardiol 1992;69:1553-1558.
51. Lauer MS, Lytle B, Pashkow F, et al. Prediction of death and myocardial infarction by screening with exercisethallium testing after coronary-artery- bypass grafting. Lancet 1998;351:615-622.
52. Giedd KN, Bergmann SR. Myocardial perfusion imaging following percutaneous coronary intervention: the importance of restenosis, disease progression, and directed reintervention. J Am Coll Cardiol 2004;43: 328-336.
53. Zellweger MJ, Weinbacher M, Zutter AW, et al. Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting. J Am Coll Cardiol 2003; 42:33-40.
54. Brindis RG, Douglas PS, Hendel RC, et al. ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. J Am Coll Cardiol 2005;46:1587-1605.
55. Zellweger M, Lewin H, Shenghan L, et al. When to stress patients after coronary artery bypass surgery? Risk stratification in patients early and late post-CABG using stress myocardial perfusion SPECT: Implications of appropriate clinical strategies. J Am Coll Cardiol 2001;37:144-152.